Drugs / BCD-147
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03912441 | Jan → Sep 2019 | — | Biocad | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCD-147 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03912441 ↗ |
| Modality | Monoclonal antibody | “Bispecific anti-HER2 monoclonal antibody” NCT03912441 ↗ |